Andere talen Alembic Pharmaceuticals Limited

Aandelen

APLLTD

INE901L01018

Beurs gesloten - NSE India S.E. Andere beurzen 13:43:46 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
990,2 ^INR	-0,73%		+5,53%	+30,40%

02/04	Alembic Pharmaceuticals benoemt Manish Kejriwal tot Onafhankelijk Bestuurder	CI
02/04	Alembic Pharmaceuticals krijgt voorlopige goedkeuring van de Amerikaanse FDA voor generieke behandeling tegen borstkanker	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3%	18/04
Alembic Pharmaceuticals Limited Received 3 Assessment Orders from the Office of Assistant Commissioner (ST), Andhra Pradesh	08/04
Alembic Pharmaceuticals Appoints Manish Kejriwal as Independent Director	02/04
Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment	02/04
Alembic Pharmaceuticals Limited Receives One US Food & Drug Administration Product Approval	01/04
Alembic Pharmaceuticals Limited Announces Board Cessations	01/04
Alembic Pharmaceuticals Limited Receives Order from Commission of Customs, Mumbai Zone- III	18/03
Alembic Pharmaceuticals' Oncology Plant in Gujarat, India Gets One Observation from US FDA	11/03
Alembic Pharmaceuticals Limited Announces United States Food and Drug Administration Conducted an Inspection At Oncology Formulation Facility At Panelav	08/03
Crisil Keeps AA+ Rating on Alembic Pharmaceuticals' Bank Loans with Stable Outlook	08/03
Indian shares seen muted tracking broader Asian equities	26/02
Alembic Pharmaceuticals Fully Resumes Operations at Manufacturing Unit in South Sikkim, India	23/02
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q3; EPS Tops Estimates	06/02
Alembic Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q3, EPS Beats Estimates	06/02
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales	05/02
Alembic Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	05/02
Alembic Pharmaceuticals Limited Announces Designation of Manuj Desai as Head - It as Senior Management Personnel	05/02
Alembic Pharmaceuticals Expects Operations at Sikkim, India Units to Be Restores in Two Months	05/01
Alembic Pharmaceuticals Extends Corporate Guarantee to US-Based Arm to Secure Credit	03/01
Alembic Pharmaceuticals Receives Various Us Food & Drug Administration Product Approvals	01/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Alembic Pharmaceuticals Limited

Aandelen

APLLTD

INE901L01018

Andere talen

Filters